Proskauer Rose LLP has advised Benitec Biopharma Inc. Mintz has advised the underwriters and placement agents. Benitec Biopharma Inc., a clinical-stage biotechnology company, has completed an...
You must be a Standard 1 Year member to access this content.
Gibson Dunn and Goodwin Procter has advised Dianthus Therapeutics, Inc., while Cooley has represented the underwriters. Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused on antibody...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati has advised Forte Biosciences, Inc. on the offering, and Paul Hastings has advised the underwriters. Forte Biosciences, Inc., a clinical-stage biopharmaceutical...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MNTN, Inc. in the offering, and Fenwick & West represented the underwriters. MNTN, Inc. (NYSE: MNTN) announced its initial public offering. The...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Palomar Holdings on the offering, while Latham & Watkins advised the Underwriters. Palomar Holdings, Inc. (NASDAQ: PLMR) announced its public offering of 1,380,000...
You must be a Standard 1 Year member to access this content.
Skadden is advising the underwriters in the offering. Lithium Americas Corp.’s announcement of the pricing of its previously announced underwritten public offering of 55,000,000 of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised AppLovin Corporation on the deal, and Fenwick & West advised the underwriters. AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”),...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
You must be a Standard 1 Year member to access this content.
